Biogen to sell stake in Samsung Bioepis JV for up to $2.3bn

Biogen to sell stake in Samsung Bioepis JV for up to $2.3bn

Source: 
Biopharma Reporter
snippet: 

Biogen will sell its equity stake in the biosimilars joint venture to Samsung Biologics for up to $2.3bn.